| __timestamp | Madrigal Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 68205000 | 19586000 |
| Thursday, January 1, 2015 | 54218000 | 29135000 |
| Friday, January 1, 2016 | 15934000 | 42791000 |
| Sunday, January 1, 2017 | 24390000 | 49577000 |
| Monday, January 1, 2018 | 25389000 | 89209000 |
| Tuesday, January 1, 2019 | 72324000 | 69099000 |
| Wednesday, January 1, 2020 | 184809000 | 75961000 |
| Friday, January 1, 2021 | 205164000 | 90467000 |
| Saturday, January 1, 2022 | 245441000 | 74552000 |
| Sunday, January 1, 2023 | 271823000 | 91593000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Madrigal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Madrigal Pharmaceuticals increased its R&D spending by nearly 300%, peaking in 2023 with a 272% rise from its 2014 levels. This aggressive investment underscores Madrigal's strategic focus on pioneering new treatments. In contrast, Supernus Pharmaceuticals exhibited a more conservative approach, with a 368% increase in R&D spending from 2014 to 2023, yet maintaining a steadier growth trajectory.
These divergent strategies highlight the varied paths companies take in the pursuit of innovation, reflecting their unique market positions and long-term goals.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Amgen Inc. vs Madrigal Pharmaceuticals, Inc.
R&D Insights: How Sanofi and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Supernus Pharmaceuticals, Inc.
R&D Insights: How Genmab A/S and Madrigal Pharmaceuticals, Inc. Allocate Funds
Incyte Corporation or Madrigal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
Veracyte, Inc. or Supernus Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.